Related by context. Frequent words. (Click for all words.) 67 includes iFinix RealTime 66 addressing idiopathic pulmonary 65 Amphion Innovations plc 65 Attracting Bullish Investors 64 Files Shelf Registration Statement 64 Tissue Repair Company 64 Jumps Higher 64 Earnings Postmortem 64 Cephalon Oncology 63 Welcomes Analyst Initiation 63 iFinix Trader 63 oncolytic virus therapies 63 Inc Therapeutic Competitors 63 fibrosis IPF 63 LungAlert TM 63 MassARRAY R 62 PRIMECAP Management 62 Announce Merger Agreement 62 novel anti infective 62 Therapeutic Competitors 62 orthobiologic 61 proprietary biomaterials 61 Nasdaq CRXL 61 http:/www.national.com 61 AXYS Design Automation 61 silico predictive discovery 61 Bearish Speculation 61 Bearish Pressure Building 61 ZFP technology 61 DuPont www.dupont.com 61 Announces Licensing Agreement 61 satellite telephones simplex 60 SWOT Analysis Aarkstore Enterprise 60 polymer electro optic 60 * Azixa 60 Bullish Speculation 60 www.vivus.com 60 produces Chrysler Jeep 60 Joins OTCQX 60 Lattice Incorporated 60 Declares Dividend Quick Facts 60 regarding Aethlon Medical 60 Inc.announced 60 liver cancers hypercholesterolemia 60 Sangamo ZFP technology 60 strategy GlobalData summarization 60 www.implantsciences.com 60 oncology immunology 59 Exploit collaboration 59 immunodiagnostic 59 Accountancy Age Computing 59 Monthly Dividend Declaration 59 severe degenerative ischemic 59 Other ImmunoGen collaborative 59 own Z# 3DVisor 59 Nanomanufacturing Technology TM 59 bio therapeutics 59 DWS Trust 59 non personalized allogeneic 59 proprietary Tissue Repair 59 Completes Merger With 59 Mercury BTO offerings 59 BIOLASE principal 59 Wholly owned Nike 59 Biodefense Division 59 Crucell NV NYSE Euronext 59 Therapeutic Competitors Report 59 unique PER.C6 ® 59 MultiCell Technologies 59 Myotech 59 please visit www.mscsoftware.com 59 GVAX cancer 59 Ibis T# 59 Chemokine Therapeutics 59 PhaseBio 59 InnerCool Therapies 59 strategy summarization 59 Initiates Phase II 59 NASDAQ CRXL 59 Cerus Corporation 59 inflammatory autoimmune diseases 59 Inc. NASDAQ MBLX 59 Guides Inline 58 Shareholders Approve Acquisition 58 based pretargeting methods 58 VP Exercises Options 58 leading lipid nanoparticle 58 www.amagpharma.com 58 commercializing therapeutic 58 CSMG Technologies Inc. 58 -Metevier 58 Ken Heebner sold 58 performance amplifiers comparators 58 Prism Pharmaceuticals 58 Additionally MorphoSys 58 wachoviasec.com 58 CMVT.PK 58 please visit http:/www.redchip.com/visibility/proeosinophilia 58 molecular diagnostics laboratories 58 Tradewinds Rittenhouse Symphony 58 SWOT Profile